Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Intelligencia

Advertisement

Articles by Intelligencia

Elevate and De-Risk Your Drug Portfolio Strategy With AI

Elevate and De-Risk Your Drug Portfolio Strategy With AI

ByIntelligencia
July 18th 2024

Webcasts

Webinar Date/Time: Wed, Aug 28, 2024 11:00 AM EDT

Advertisement

Latest Updated Articles

  • Elevate and De-Risk Your Drug Portfolio Strategy With AI
    Elevate and De-Risk Your Drug Portfolio Strategy With AI

    July 18th 2024



Advertisement
Advertisement

Trending on PharmExec

1

Novo Reports Real-World Data Showing Weight Loss After Switch to Oral Semaglutide Pill

2

Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboartion with Summit Therapeutics

3

New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report

4

As Peptide Rulemaking Stalls, FDA Enforcement Moves Forward

5

Pharmaceutical Executive Daily: Peptide Ruling Stalls

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us